CONTROVERSIES IN THE MANAGEMENT OF EARLY-STAGE HODGKINS-DISEASE

被引：55

作者：

MAUCH, PM

机构：

来源：

BLOOD | 1994年 / 83卷 / 02期

关键词：

D O I：

10.1182/blood.V83.2.318.bloodjournal832318

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：318 / 329

页数：12

共 151 条

[61] THE PLACE OF RADIOTHERAPY IN THE MANAGEMENT OF LOCALIZED HODGKINS-DISEASE .11. [J].

HOPESTONE, HF .

CLINICAL RADIOLOGY, 1981, 32 (05) :519-522

[62]

HOPPE R, 1989, CURRENT STANFORD CLI, P182

[63] THE MANAGEMENT OF STAGE-II HODGKINS-DISEASE WITH A LARGE MEDIASTINAL MASS - A PROSPECTIVE PROGRAM EMPHASIZING IRRADIATION [J].

HOPPE, RT .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (02) :349-355

[64]

HOPPE RT, 1982, BLOOD, V59, P455

[65] VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE [J].

HORNING, SJ ;

HOPPE, RT ;

HANCOCK, SL ;

ROSENBERG, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1822-1831

[66]

JACQUILLAT C, 1984, CANCER, V53, P459, DOI 10.1002/1097-0142(19840201)53:3<459::AID-CNCR2820530315>3.0.CO

[67]

2-V

[68] PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL AFTER HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE [J].

JAGANNATH, S ;

ARMITAGE, JO ;

DICKE, KA ;

TUCKER, SL ;

VELASQUEZ, WS ;

SMITH, K ;

VAUGHAN, WP ;

KESSINGER, A ;

HORWITZ, LJ ;

HAGEMEISTER, FB ;

MCLAUGHLIN, P ;

CABANILLAS, F ;

SPITZER, G .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) :179-185

[69]

JENSEN BV, 1990, EUR J HAEMATOL, V44, P165

[70] THE SIGNIFICANCE OF THE RESIDUAL MEDIASTINAL MASS IN TREATED HODGKINS-DISEASE [J].

JOCHELSON, M ;

MAUCH, P ;

BALIKIAN, J ;

ROSENTHAL, D ;

CANELLOS, G .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) :637-640

← 2 3 4 5 6 7 8 9 10 11 →